DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,906,159 | +2.8% | 4,067,332 | +0.0% | 0.02% | +8.7% |
| Q2 2023 | $48,544,076 | +6.6% | 4,065,668 | +19.3% | 0.02% | 0.0% |
| Q1 2023 | $45,549,861 | -14.4% | 3,406,871 | +37.8% | 0.02% | -17.9% |
| Q4 2022 | $53,215,710 | +7.3% | 2,472,849 | -0.2% | 0.03% | +3.7% |
| Q3 2022 | $49,608,000 | +12.4% | 2,476,706 | +0.5% | 0.03% | +22.7% |
| Q2 2022 | $44,130,000 | +188.3% | 2,465,380 | +59.8% | 0.02% | +266.7% |
| Q1 2022 | $15,305,000 | -5.5% | 1,542,859 | +60.5% | 0.01% | 0.0% |
| Q4 2021 | $16,197,000 | +15.6% | 961,226 | +62.8% | 0.01% | +20.0% |
| Q3 2021 | $14,013,000 | +18.6% | 590,527 | +13.8% | 0.01% | 0.0% |
| Q2 2021 | $11,817,000 | – | 518,966 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |